Quadira Biosciences

Quadriga BioSciences, Inc. is a private pharmaceutical company developing proprietary targeted cancer therapies. Our technology is based on the discovery that many aggressive forms of cancer cells overexpress certain unique amino acid transporters on their cell surface to uptake nutrients to support rapid tumor growth and proliferation. Leveraging this biological characteristic, Quadriga is developing novel targeted molecules aimed at cancer cells that overexpress these transporters. Our mission is to develop safer and more effective treatments for cancer patients.